Literature DB >> 9790973

Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells.

A K Behera1, M Kumar, H Matsuse, R F Lockey, S S Mohapatra.   

Abstract

Respiratory syncytial virus (RSV) infection causes and exacerbates asthma, yet the mechanism by which RSV triggers asthma is poorly understood. Herein, an in vitro model of RSV infection was established using HEp-2 and BEAS-2B bronchial epithelial cell lines, and the expression of 5-lipoxygenase (5-LO), and endothelin-1 (ET-1) was examined. RSV infection increased the expression of 5-LO mRNA and protein in both cell lines, as detected by RT-PCR and western blot analysis, respectively. The levels of leukotrienes also increased in the supernatants of RSV infected cells. Furthermore, RSV infection increased the expression of ET-1 mRNA and protein following RSV infection in a time-dependent manner. It is concluded that RSV infection upregulates the expression of ET-1 and 5-LO in the epithelial cells leading to the production of leukotrienes, which may mediate the consequent exacerbation of asthma. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790973     DOI: 10.1006/bbrc.1998.9537

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Expression of 5-lipoxygenase in specialized epithelial cells of nasopharyngeal-associated lymphoid tissue.

Authors:  Thomas G Brock
Journal:  J Mol Histol       Date:  2006-04-28       Impact factor: 2.611

Review 2.  Evolving role of leukotrienes in the pathogenesis of viral infections, including otitis media.

Authors:  Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

3.  Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4.

Authors:  J Gosselin; M Savard; M Tardif; L Flamand; P Borgeat
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Authors:  Kate L Stokes; Michael H Chi; Kaori Sakamoto; Dawn C Newcomb; Michael G Currier; Matthew M Huckabee; Sujin Lee; Kasia Goleniewska; Carla Pretto; John V Williams; Anne Hotard; Taylor P Sherrill; R Stokes Peebles; Martin L Moore
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Endocervical and Neutrophil Lipoxygenases Coordinate Neutrophil Transepithelial Migration to Neisseria gonorrhoeae.

Authors:  Jacqueline S Stevens; Mary C Gray; Christophe Morisseau; Alison K Criss
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

6.  In Vitro Effects of 5-Lipoxygenase Pathway Inhibition on Rhinovirus-Associated Bronchial Epithelial Inflammation.

Authors:  Irini Spyridaki; Styliani Taka; Chrysanthi Skevaki; Aikaterini Trochoutsou; Nikolaos G Papadopoulos
Journal:  Pulm Ther       Date:  2021-04-13

7.  An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.

Authors:  Xiaoyuan Kong; Gary R Hellermann; Geoff Patton; Mukesh Kumar; Aruna Behera; Timothy S Randall; Jian Zhang; Richard F Lockey; Shyam S Mohapatra
Journal:  Virol J       Date:  2005-02-08       Impact factor: 4.099

8.  Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cells.

Authors:  Nicole M Kuderer; Homero G San-Juan-Vergara; Xiaoyuan Kong; Robert Esch; Richard F Lockey; Shyam S Mohapatra
Journal:  Clin Mol Allergy       Date:  2003-10-30

9.  Enhanced cysteinyl-leukotriene type 1 receptor expression in T cells from house dust mite-allergic individuals following stimulation with Der p.

Authors:  Maryse Thivierge; Sylvie Turcotte; Marek Rola-Pleszczynski; Jana Stankova
Journal:  J Immunol Res       Date:  2015-03-31       Impact factor: 4.818

10.  Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology.

Authors:  K A Shirey; W Lai; L M Pletneva; C L Karp; S Divanovic; J C G Blanco; S N Vogel
Journal:  Mucosal Immunol       Date:  2013-09-25       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.